Oophorectomy cuts risk of cancer in BRCA1/2 carriers

Article

A study by Canadian researchers shows that preventive oophorectomy reduces risk of ovarian, fallopian tube, or peritoneal cancer by 80% in women who have BRCA1 or BRCA2 mutations. Published in The Journal of Clinical Oncology, the report also documented a 77% reduction in all-cause mortality.

 

A study by Canadian researchers shows that preventive oophorectomy reduces risk of ovarian, fallopian tube, or peritoneal cancer by 80% in women who have BRCA1 or BRCA2 mutations. Published in The Journal of Clinical Oncology, the report also documented a 77% reduction in all-cause mortality.

An international registry was used to identify 5783 women with a BRCA1 or BRCA2 mutation, who then completed a baseline questionnaire and at least one follow-up questionnaire. The participants were observed until they were diagnosed with ovarian, fallopian, or peritoneal cancer, death, or date of most recent follow-up. The goal was to assess the impact of prophylactic oophorectomy on all-cause mortality and estimate 5-year survival associated with clinically detected ovarian, occult, and peritoneal cancers diagnosed in the cohort.

After average follow up of 5.6 years, a total 186 women developed ovarian (n=132), fallopian (n=22), or peritoneal (32) cancer, 68 of whom have died. Bilateral oophorectomy was associated with a hazard ratio (HR) for ovarian, fallopian, or peritoneal cancer of 0.20 (95% CI, 0.13 to 0.30; P< .001). The HR for all-cause mortality at age 70 years associated with oophorectomy was 0.23 (95% CI, 0.13 to 0.39; P< .001) for women who had no history of cancer at baseline.  

 

 

To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Susan Khalil, MD
Negative pressure wound therapy reduces c-section infections and costs | Image Credit: doctors.valleyhealth.com.
Megan Wasson, DO, FACOG
Wasson and Colak
Non-hormonal treatments offer relief for genitourinary syndrome of menopause | Image Credit: providers.uthscsa.edu.
Chemen M. Neal, MD, discusses weekly secnidazole for bacterial vaginosis treatment | Image Credit: medicine.iu.edu
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
Ipek Ensari, PhD, highlights improved mental health in chronic pelvic pain from physical activity | Image Credit: scholars.mssm.edu
Evaluating a miniature robotic device for hysterectomy | Image Credit: linkedin.com.
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.